Implanet S.A. (EPA:ALIMP)
France · Delayed Price · Currency is EUR 0.2790
-0.0210 (-7.00%)
Sep 5, 2025, 5:35 PM CET
Implanet Revenue
In the year 2024, Implanet had annual revenue of 9.41M EUR with 26.31% growth. Implanet had revenue of 5.29M in the half year ending December 31, 2024, with 35.06% growth.
Revenue
9.41M
Revenue Growth
+26.31%
P/S Ratio
3.73
Revenue / Employee
204.48K
Employees
46
Market Cap
35.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.41M | 1.96M | 26.31% |
| Dec 31, 2023 | 7.45M | -581.00K | -7.24% |
| Dec 31, 2022 | 8.03M | 1.89M | 30.75% |
| Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
| Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |